Alcon Agrees to Acquire LENSAR for $430 Million
Deal News | Mar 24, 2025 | Globenewswire
Alcon, a leader in eye care solutions, has entered into a definitive agreement to acquire LENSAR, a medical technology company specializing in advanced laser solutions for cataract treatments. The acquisition involves the integration of LENSAR's ALLY Robotic Cataract Laser Treatment System and its proprietary Streamline software. The transaction is valued at $14.00 per share with a total potential consideration of up to $430 million, contingent on achieving certain milestones. This acquisition is expected to enhance Alcon's femtosecond laser-assisted cataract surgery offerings and increase its global footprint in providing innovative cataract solutions. The merger is set to conclude by mid-to-late 2025, subject to customary approvals.
Sectors
- Medical Devices
- Healthcare Technology
Geography
- United States – LENSAR is based in Orlando, Florida, and part of the transaction and regulatory approvals will occur within the U.S.
- Switzerland – Alcon is headquartered in Geneva, Switzerland, making this a significant geography in terms of company operations and strategic moves.
Industry
- Medical Devices – The article discusses the acquisition of LENSAR, a company that develops medical devices for cataract surgery, by Alcon, which strengthens its portfolio in the medical device industry.
- Healthcare Technology – As the article covers advanced laser solutions and software technology used in cataract surgery, it is relevant to the healthcare technology sector.
Financials
- $356 million – The implied value of the acquisition based on the purchase price of $14.00 per share.
- $430 million – Total potential consideration of the acquisition if certain milestones are met.
- $2.75 per share – Additional contingent value based on future performance milestones.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Alcon | Acquiring Company | Company | A global leader in eye care focused on improving people’s vision with innovative products. |
| LENSAR, Inc. | Target Company | Company | A medical technology company specializing in advanced laser solutions for cataract surgery. |
| Lazard | Financial Advisor | Company | Advising Alcon in the acquisition of LENSAR. |
| Norton Rose Fulbright | Legal Advisor | Company | Providing legal advice to Alcon for the transaction. |
| Wells Fargo | Financial Advisor | Company | Advising LENSAR in the acquisition process. |
| Latham & Watkins LLP | Legal Advisor | Company | Providing legal advice to LENSAR for the transaction. |